
|Articles|October 1, 2012
Various factors dictate which neuromodulator to use, and when
As research and clinical experience continue to underscore differences between the three neuromodulators available in the United States, picking a product for a given clinical situation rests largely upon individual preference, according to Joel L. Cohen, M.D., who spoke earlier this year at MauiDerm 2012: Advances in Cosmetic and Medical Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: Hydrocolloid Pimple Patches
2
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
3
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
4
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
5











